These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28089761)

  • 41. 2016 proceedings of the National Heart, Lung, and Blood Institute's scientific priorities in pediatric transfusion medicine.
    Cure P; Bembea M; Chou S; Doctor A; Eder A; Hendrickson J; Josephson CD; Mast AE; Savage W; Sola-Visner M; Spinella P; Stanworth S; Steiner M; Mondoro T; Zou S; Levy C; Waclawiw M; El Kassar N; Glynn S; Luban NLC
    Transfusion; 2017 Jun; 57(6):1568-1581. PubMed ID: 28369923
    [No Abstract]   [Full Text] [Related]  

  • 42. Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients.
    Klausen SS; Hervig T; Seghatchian J; Reikvam H
    Transfus Apher Sci; 2014 Oct; 51(2):97-102. PubMed ID: 25242310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Ethics in blood transfusion: A passion for teachers and students].
    Garraud O; Tissot JD; Hervé C
    Transfus Clin Biol; 2016 Sep; 23(3):117-8. PubMed ID: 27460998
    [No Abstract]   [Full Text] [Related]  

  • 44. [New trends in the clinical use of platelet transfusions].
    Gota F; Lombardi A
    Arch Sci Med (Torino); 1980; 137(2):327-9. PubMed ID: 7224853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The human pegivirus: A new name for an "ancient" virus. Can transfusion medicine come up with something new?
    Marano G; Franchini M; Farina B; Piccinini V; Pupella S; Vaglio S; Grazzini G; Liumbruno GM
    Acta Virol; 2017; 61(4):401-412. PubMed ID: 29186957
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Control of the bacterial risk of transfusion in France in 2013].
    Morel P; Deschaseaux M; Bertrand X; Naegelen C; Leconte des Floris MF; Bardiaux L
    Transfus Clin Biol; 2013 May; 20(2):174-81. PubMed ID: 23622838
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A RECOMMENDATION FOR SAFER BLOOD TRANSFUSIONS.
    BURROWS S
    Pa Med J; 1964 Jul; 67():33-4. PubMed ID: 14178521
    [No Abstract]   [Full Text] [Related]  

  • 48. Why industrial production of red blood cells from stem cells is essential for tomorrow's blood transfusion.
    Douay L
    Regen Med; 2018 Sep; 13(6):627-632. PubMed ID: 30246611
    [No Abstract]   [Full Text] [Related]  

  • 49. Transfusion-transmissible infection monitoring system: a tool to monitor changes in blood safety.
    Custer B; Stramer SL; Glynn S; Williams AE; Anderson SA
    Transfusion; 2016 Jun; 56(6 Pt 2):1499-502. PubMed ID: 27295025
    [No Abstract]   [Full Text] [Related]  

  • 50. Closing the circle: a thirty-year retrospective on the AIDS/blood epidemic.
    Dubin C; Francis D
    Transfusion; 2013 Oct; 53(10 Pt 2):2359-64. PubMed ID: 24032638
    [No Abstract]   [Full Text] [Related]  

  • 51. [Drug use in blood donors].
    Berg JA; Schjøtt J
    Tidsskr Nor Laegeforen; 2016 May; 136(8):718-20. PubMed ID: 27143462
    [No Abstract]   [Full Text] [Related]  

  • 52. Transfusion practices in the 1990s.
    Menitove JE
    Annu Rev Med; 1991; 42():297-309. PubMed ID: 2035975
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Blood donor hemovigilance: impact for donor and recipient safety].
    Hauser L; Beyloune A; Simonet M; Bierling P
    Transfus Clin Biol; 2013 May; 20(2):99-103. PubMed ID: 23587614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emerging haemostatic agents and patient blood management.
    Tanaka KA; Kor DJ
    Best Pract Res Clin Anaesthesiol; 2013 Mar; 27(1):141-60. PubMed ID: 23590923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Transfusion safety. Introduction and identifying the problem].
    Ambriz Fernández R
    Gac Med Mex; 2013; 149(1):73-80. PubMed ID: 23435078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current advances in transfusion medicine 2020: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee.
    Allen ES; Cohn CS; Bakhtary S; Dunbar NM; Gniadek T; Hopkins CK; Jacobson J; Lokhandwala PM; Metcalf RA; Murphy C; Prochaska MT; Raval JS; Shan H; Storch EK; Pagano MB
    Transfusion; 2021 Sep; 61(9):2756-2767. PubMed ID: 34423446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The current status of platelet and granulocyte transfusions.
    Seidl S; Kilp M
    Haematologia (Budap); 1980; 13(1-4):145-54. PubMed ID: 7019021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Haemovigilance.
    Karim F; Ali N; Adil SN
    J Pak Med Assoc; 2012 Dec; 62(12):1270. PubMed ID: 23866470
    [No Abstract]   [Full Text] [Related]  

  • 59. [The status of blood component therapy in East Germany].
    Fünfhausen G
    Beitr Infusionsther; 1988; 21():354-6. PubMed ID: 2463009
    [No Abstract]   [Full Text] [Related]  

  • 60. Designing and Implementing a 5-Year Transfusion Medicine Diploma Program in China.
    Li T; Wang W; Zhang L; Zhou Y; Lai F; Fu Y; Wang C; Yang B; Zhu W; Wu Y; Allain JP; Stevens L; Li C
    Transfus Med Rev; 2017 Apr; 31(2):126-131. PubMed ID: 27931768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.